Certara Pinnacle 21 Data Exchange – Vendor Data Reconciliation Software Video Certara Pinnacle 21 Data Exchange – Vendor Data Reconciliation Software External vendors provide more than seventy percent of today's trial data without the help of…Danielle PillsburyMarch 31, 2026
Certara Pinnacle 21 Enterprise Plus – SDTM mapping specifications Video Certara Pinnacle 21 Enterprise Plus – SDTM mapping specifications Mapping clinical data to CDISC SDTM is mandatory for clinical trial submissions. But accurately mapping…Danielle PillsburyMarch 31, 2026
Platforms for collaboration between sponsors and CROs: 5 ways CROs can scale efficiently while maximizing validation assurance Blog Platforms for collaboration between sponsors and CROs: 5 ways CROs can scale efficiently while maximizing validation assurance Platforms for collaboration between sponsors and CROs provide validation assurance & improve sponsor outcomes with…CertaraMarch 31, 2026
Data Fabrics in Pharma: Connecting Data for Better Decisions Blog Data Fabrics in Pharma: Connecting Data for Better Decisions Learn how a data fabric in pharma connects siloed systems. Explore the benefits of data…CertaraMarch 31, 2026
Pinnacle 21 Community or Enterprise: How to decide which is right for your study Webinar Pinnacle 21 Community or Enterprise: How to decide which is right for your study CertaraMarch 27, 2026
How Bayesian Design Is Reshaping Clinical Development Press CoverageVideo How Bayesian Design Is Reshaping Clinical Development Learn how Bayesian design is reshaping clinical trials with adaptive methods that improve efficiency, reduce…CertaraMarch 27, 2026
Where Did the 80-125% Bioequivalence Criteria Come From? BlogKnowledge Base Where Did the 80-125% Bioequivalence Criteria Come From? Discover what bioequivalence criteria mean, why the 80-125% bioequivalence range is used, and how custom…CertaraMarch 27, 2026
Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection Case Study Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection PK/PD Modeling for CNS drug development using Phoenix NLME and machine learning for better CNS…CertaraMarch 26, 2026
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics Publication Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics This review article examines the development of radiopharmaceutical imaging agents and radioligand therapies for pediatric…CertaraMarch 26, 2026
Shaping the Future of Medical Writing: Key Themes for 2026 Blog Shaping the Future of Medical Writing: Key Themes for 2026 Five key themes and their implications for leaders shaping their Medical Writing strategy for 2026CertaraMarch 26, 2026